Story perspectives

Gene Editing Market Set to Double by 2032

9/17/2025

50 3

Summary

Story summary

The global Gene Editing Market is expected to grow from $4.80 billion in 2025 to $9.51 billion by 2032, reflecting a CAGR of 10.2%.
Key segments encompass product types, applications, and end-users, primarily in pharmaceuticals and biotechnology.
The RNA Editing Therapies Market is advancing, focusing on genetic diseases and personalized medicine.
Growth drivers include increased investment, strategic partnerships, and advancements in RNA delivery technologies.
North America leads both markets, supported by strong funding and a robust biotech ecosystem.

1 of 1

Story summary

The global Gene Editing Market is expected to grow from $4.80 billion in 2025 to $9.51 billion by 2032, reflecting a CAGR of 10.2%.
Key segments encompass product types, applications, and end-users, primarily in pharmaceuticals and biotechnology.
The RNA Editing Therapies Market is advancing, focusing on genetic diseases and personalized medicine.
Growth drivers include increased investment, strategic partnerships, and advancements in RNA delivery technologies.
North America leads both markets, supported by strong funding and a robust biotech ecosystem.